###begin article-title 0
###xml 11 34 11 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 11 33 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 83 106 83 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 360 369 360 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 83 105 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
The endoglycosidase EndoS and the cysteine proteinase SpeB from the human pathogen Streptococcus pyogenes are functionally related in that they both hydrolyze IgG leading to impairment of opsonizing antibodies and thus enhance bacterial survival in human blood. In this study, we further investigated the relationship between EndoS and SpeB by examining their in vitro temporal production and stability and activity of EndoS. Furthermore, theoretical structure modeling of EndoS combined with site-directed mutagenesis and chemical blocking of amino acids was used to identify amino acids required for the IgG glycan-hydrolyzing activity of EndoS.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 33 54 33 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro S. pyogenes </italic>
###xml 42 53 <span type="species:ncbi:1314">S. pyogenes</span>
We could show that during growth in vitro S. pyogenes secretes the IgG glycan-hydrolyzing endoglycosidase EndoS prior to the cysteine proteinase SpeB. Upon maturation SpeB hydrolyzes EndoS that then loses its IgG glycan-hydrolyzing activity. Sequence analysis and structural homology modeling of EndoS provided a basis for further analysis of the prerequisites for IgG glycan-hydrolysis. Site-directed mutagenesis and chemical modification of amino acids revealed that glutamic acid 235 is an essential catalytic residue, and that tryptophan residues, but not the abundant lysine or the single cysteine residues, are important for EndoS activity.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We present novel information about the amino acid requirements for IgG glycan-hydrolyzing activity of the immunomodulating enzyme EndoS. Furthermore, we show that the cysteine proteinase SpeB processes/degrades EndoS and thus emphasize the importance of the SpeB as a degrading/processing enzyme of proteins from the bacterium itself.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 27 50 27 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 191 203 191 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 865 873 865 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1020 1032 1020 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 1523 1524 1523 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 27 49 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 191 202 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 545 550 <span type="species:ncbi:9606">human</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
###xml 804 810 <span type="species:ncbi:9606">humans</span>
###xml 1020 1031 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1480 1485 <span type="species:ncbi:10090">mouse</span>
Extracellular enzymes from Streptococcus pyogenes have been extensively studied and shown to be of importance for the pathogenesis of this human pathogen (for a review see [1]). The secreted S. pyogenes enzyme EndoS (AAK00850) has a specific endoglycosidase activity on native human IgG by hydrolyzing the conserved asparagine-linked glycans found on each heavy chain of IgG [2]. EndoS-activity affects the functionality of opsonizing IgG by decreased binding to Fc-receptors and impaired classical complement activation, and EndoS treatment of human opsonizing IgG antibodies directed towards the cell-wall anchored M protein significantly enhances bacterial survival in human blood [3]. The ndoS gene encoding EndoS is present in all tested isolates, and is highly conserved. Both healthy and infected humans have circulating antibodies against EndoS, suggesting in vivo expression [4]. In addition, EndoS is up regulated when interacting with white blood cells [5]. The activity of EndoS on IgG may be beneficial for S. pyogenes expressing this enzyme with modulation and/or evasion of an IgG-mediated response against the bacteria. In contrast to this, the purified form of EndoS has substantial potential as a therapeutical agent against antibody-mediated autoimmune diseases and other conditions where IgG is involved in pathological processes. It has recently been shown that pre-treatment of arthritogenic IgG antibodies with EndoS abrogates development of arthritis in a mouse model of collagen-induced arthritis [6].
###end p 9
###begin p 10
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 531 533 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 534 536 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 774 776 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 777 779 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 491 496 <span type="species:ncbi:9606">human</span>
One of the most studied streptococcal enzymes is the cysteine proteinase, SpeB. Several in vitro and in vivo studies, as well as clinical studies have suggested a role for SpeB as an important virulence factor [7-9]. SpeB has the ability to degrade the human extracellular matrix protein fibronectin and vitronectin, release inflammatory mediators such as interleukin 1beta and bradykinin from their precursors, cleave or degrade immunoglobulins and complement factors, and also bind to the human cell surface receptors integrins [10-17]. In addition, SpeB releases active fragments from cell wall-anchored proteins from the bacterium itself, cleaves the secreted pore-forming streptolysin O that retains its cytolytic activity after processing, and degrades superantigens [18-20].
###end p 10
###begin p 11
###xml 20 32 20 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 20 31 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
EndoS and SpeB from S. pyogenes are functionally related in that they both hydrolyze IgG leading to impairment of opsonizing antibodies and thus enhance bacterial survival in human blood [3].
###end p 11
###begin p 12
###xml 98 107 98 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
In this study, we further investigated the relationship between EndoS and SpeB by examining their in vitro temporal production and reveal a novel activity of SpeB; processing and eventually complete degradation of EndoS with loss of its IgG hydrolyzing activity. Furthermore, theoretical structure modeling of EndoS combined with site-directed mutagenesis and chemical blocking of amino acids identified amino acids required for the IgG glycan-hydrolyzing activity of EndoS.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
Temporal production of EndoS and SpeB
###end title 14
###begin p 15
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 0 11 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 257 263 <span type="species:ncbi:9986">rabbit</span>
S. pyogenes strain AP1 was cultured in a medium for optimal expression of EndoS and SpeB [2,21], and culture supernatant samples were withdrawn at indicated time points (Fig. 1A). Secretion of SpeB and EndoS was analyzed using Western blots with polyclonal rabbit antiserum raised against the zymogen form of SpeB and full-length EndoS. Expression of intact EndoS (108 kDa) was observed after approximately 9 hours in late exponential growth phase (Fig. 1A and 1B). However, when samples were collected at 12 hours of incubation an additional band with an apparent mass of 62 kDa reacted with the EndoS antibodies (Fig. 1A and 1B). Furthermore, the total amount of the 62 kDa band decreased between 15 and 24 hours of culturing suggesting further degradation of this fragment of EndoS. Interestingly, the appearance of this 62 kDa EndoS fragment coincides with the maturation and processing of SpeB from its 40 kDa zymogen form into its proteolytically active 28 kDa form (Fig. 1C). This observation suggested that SpeB is involved in the processing/degradation of EndoS, and we hypothesized that this could be of importance in regulating EndoS activity.
###end p 15
###begin p 16
###xml 45 57 45 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Secretion of EndoS and SpeB during growth of <italic>S. pyogenes </italic>strain AP1</bold>
###xml 45 56 <span type="species:ncbi:1314">S. pyogenes</span>
Secretion of EndoS and SpeB during growth of S. pyogenes strain AP1. Panel A, growth of wild type AP1 and measurements of optical density at 620 nm over time. Samples were withdrawn for analysis at indicated time points. Panel B, detection of EndoS in samples from indicated time points using antiserum against full-length EndoS. Panel C, detection of SpeB in the culture supernatants using antiserum against the 40 kDa zymogen form of SpeB.
###end p 16
###begin title 17
SpeB hydrolyzes EndoS during growth and in purified form
###end title 17
###begin p 18
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1258 1259 1258 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1393 1395 1393 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1494 1496 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1572 1577 1572 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 1679 1681 1679 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1757 1759 1757 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
In order to confirm that SpeB hydrolyzes EndoS, we cultured the wild type strain AP1 for 20 hours in CM with or without the reducing agent DTT (SpeB activity requires reducing conditions [22]) and analyzed the status of EndoS and SpeB using Western blots. Under reducing conditions the AP1 strain nearly completely degraded EndoS protein, while under the slightly reducing condition in CM alone EndoS was only partly hydrolyzed (Fig. 2A, EndoS, lanes A and B), which suggests that SpeB is responsible for the hydrolysis of EndoS. Analysis using SpeB antibodies revealed that under non-reducing conditions the AP1 strains produces mainly the 28 kDa active form of SpeB, but some 40 kDa could be detected, while under reducing conditions only the active form of SpeB could be detected (Fig 2B, SpeB, lanes A and B). The 62 kDa band reacting with the EndoS antibodies in lane A figure 2A was sequenced by Edman degradation [23] revealing the sequence KDKSYDLI corresponding to amino acids 446-453 of the EndoS sequence (AAK00850). Thus, one SpeB cleavage site in EndoS is between Leu-445 and Lys-446, but smaller degradations products reacting with the antibodies could also be seen. To confirm SpeB activity on EndoS, we cultured the isogenic SpeB mutant AL1 [2,24] in CM and analyzed the supernatant as above. This showed that AL1 is unable to hydrolyze EndoS even in the presence of DTT (Fig. 2A, EndoS, lanes C and D). A confirmation that AL1 does not produce any active SpeB is seen in (Fig. 2B, SpeB, lanes C and D). As a control experiment, strain MC14 mutated in the ndoS gene was analyzed under the same conditions. This revealed that MC14 does not produce any EndoS (Fig. 2A, EndoS lanes E and F), while it still produces SpeB as wild type AP1 (Fig. 2B, SpeB, lanes E and F). Taken together, SpeB cleaves EndoS into a main 62 kDa fragment and several smaller fragments during growth, but it remained unclear whether the remainder of EndoS was completely degraded or simply not recognized by the EndoS-antibodies.
###end p 18
###begin p 19
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EndoS is hydrolyzed by SpeB</bold>
###xml 632 634 632 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink">62</bold>
EndoS is hydrolyzed by SpeB. Panel A, analysis of SpeB-hydrolysis of EndoS during growth of the wild type AP1 (lanes A and B), the SpeB mutant AL1 (lane C and D), and the EndoS mutant MC14 (lanes E and F) with antiserum against EndoS and SpeB. Presence or absence of DTT during growth is indicated under the lower panel. Arrows to the right indicate the positions of full-length EndoS (FL), the zymogen (Z) and proteinase (P) forms of SpeB. Panel B, rEndoS incubated with increasing amounts of SpeB (lanes A-E) or thermolysin (lane F) as indicated and analyzed by SDS-PAGE. Arrows to the right indicate the positions of the 46- and 62-kDa forms of EndoS, SpeB, and thermolysin. Panel C, densitometric analysis of whole lanes A-E (excluding SpeB) in panel B. Values are presented as area under the curve in pixels.
###end p 19
###begin p 20
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
To further investigate the hydrolysis of EndoS, recombinantly expressed EndoS (rEndoS) was incubated with serial dilutions of SpeB. This revealed that SpeB processes rEndoS into two major fragments of approximately 62 and 46 kDa (Fig. 2B, lane E). Visual inspection and whole lane densitometry analysis (Fig 2C) showed that the total amount of rEndoS also diminished, indicating that besides processing into two fairly stable fragments, SpeB unspecifically degrades EndoS into low molecular weight fragments. In addition, EndoS was incubated at an enzyme: substrate ratio of 1:3 with thermolysin for one hour. Despite 296 predicted thermolysin sites in the mature 108 kDa form of EndoS, two major fragments of approximately 62 and 46 kDa, similarly to what could be seen with SpeB, resisted proteolysis (Fig. 2B, lane F).
###end p 20
###begin title 21
Analysis of primary structure and homology modeling of EndoS
###end title 21
###begin p 22
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 456 481 456 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Porphyromonas gingivalis </italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 507 526 507 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium tetani </italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 568 591 568 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria monocytogenes </italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 755 767 755 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria spp</italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1144 1146 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 456 480 <span type="species:ncbi:837">Porphyromonas gingivalis</span>
###xml 507 525 <span type="species:ncbi:1513">Clostridium tetani</span>
###xml 568 590 <span type="species:ncbi:1639">Listeria monocytogenes</span>
EndoS contains a 37 amino acids N-terminal signal sequence that has been verified by amino-terminal sequencing [2], an amino-terminal part comprising amino acids 37-446 which harbors a family 18 glycosyl hydrolase active site motif at position 227-235 [25] (Fig. 3A). The remaining part (amino acids 446-995) of EndoS carboxy-terminally to the SpeB cleavage site (Fig. 3A. 446-995) is similar to leucine-rich repeat proteins (LRR's) from the oral pathogen Porphyromonas gingivalis [26], the tetanus-causing Clostridium tetani [27], and from the intracellular pathogen Listeria monocytogenes (Internalin E, InlE) [28] (Fig. 3B). No functions have been ascribed to the LRR's most similar to EndoS, but LRR's belonging the internalin family of proteins from Listeria spp. are essential for cellular attachment and internalization through binding of E-cadherin [29,30]. EndoS contains three highly similar leucine-rich repeats of approximately 37 amino acids between amino acids 459 and 589, and two additional repeats between 591 and 683 with lower leucine content and with a somewhat lower similarity as detected by the RADAR algorithm [31](Fig. 3C).
###end p 22
###begin p 23
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Possible domain organization and sequence alignments of EndoS</bold>
###xml 420 434 420 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. gingivalis </italic>
###xml 447 457 447 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. tetani </italic>
###xml 474 491 474 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L. monocytogenes </italic>
###xml 420 433 <span type="species:ncbi:837">P. gingivalis</span>
###xml 447 456 <span type="species:ncbi:1513">C. tetani</span>
###xml 474 490 <span type="species:ncbi:1639">L. monocytogenes</span>
Possible domain organization and sequence alignments of EndoS. Panel A, schematic representation of the 995 amino acids EndoS. Ss indicates signal peptide, the chitinase family 18 active site motif in the amino-terminal domain is indicated, the SpeB cleavage site is indicated with an arrow, and the putative leucine-rich repeat region (LRR) is shown. Panel B, ClustalW alignment of EndoS and leucine-rich proteins from P. gingivalis (NP_905954), C. tetani (NP_781184), and L. monocytogenes (NP_463795). Amino acid number one corresponds to amino acid 446 in the whole protein. Panel C, RADAR repeat analysis showing three 37 amino acids leucine rich repeats and two additional repeats. Numbering is based on the 995 amino acids sequence of full-length EndoS.
###end p 23
###begin p 24
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 531 533 531 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 538 569 538 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Elizabethkingia meningoseptica </italic>
###xml 579 609 579 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Flavobacterium meningosepticum</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 680 682 680 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 810 811 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink">8</sub>
###xml 949 951 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1111 1113 1088 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1355 1357 1326 1328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1402 1403 1373 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1404 1406 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1674 1676 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 538 568 <span type="species:ncbi:238">Elizabethkingia meningoseptica</span>
###xml 579 609 <span type="species:ncbi:238">Flavobacterium meningosepticum</span>
###xml 1565 1570 <span type="species:ncbi:9606">human</span>
Despite a wide variety of folds, the overall topology of glycosyl hydrolases can be divided into three main groups where the active site is within a pocket, a cleft or a tunnel. The varying degree of accessibility to the active site has been suggested to determine the carbohydrate substrate specificity [32]. Since the only substrate for EndoS known to date is the complex bi-antennary glycan on native IgG, we attempted to predict the structure of EndoS using homology modeling. Amino acids 37-446 of EndoS was aligned with EndoF3 from Elizabethkingia meningoseptica (formerly Flavobacterium meningosepticum) [33] and subjected to automated protein homology modeling using EndoF3 (PDB 1EOK) as the template. The generated model of amino acids 37-446 covers the active site and displays a typical (alpha/beta)8-barrel with eight repeated beta-strand/loop/alpha-helix units with the parallel beta-strands forming an eight-stranded beta-barrel (Fig. 4A). The putative catalytic Glu-235 residue in the FGH18 active site is located at the orifice of the beta-barrel. When superimposing the EndoS model on the EndoF3 structure, two additional antiparallel beta-strands protrudes at the top of the barrel close to the catalytic Glu residue, and there are two extended loops with antiparallel beta-strands on opposite sides of the molecule. Both EndoS and EndoF3 hydrolyse biantennary complex carbohydrates [2,33]. The modeled beta-barrel in EndoS potentially only accommodates certain glycans and could partly explain EndoS' specificity for the N-linked carbohydrate on human IgG, even though its activity has been suggested to depend on additional protein-protein interactions [34]. Hypothetically, the additional extended loops in the EndoS could contribute to the specificity by interactions with the protein backbone of the IgG heavy chain. Homology models should be interpreted with great caution, but the EndoS model could serve as a starting point for rational mutagenesis, interaction studies with IgG, and attempts to crystallize defined parts of the molecule.
###end p 24
###begin p 25
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Homology modeling of EndoS</bold>
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 210 212 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
Homology modeling of EndoS. Panel A, model of amino acids 37-446 of EndoSusing EndoF3 as the template. Glu-235 in the active is shown in red. Panel B, EndoS model (yellow) superimposed in the structure of EndoF3 (blue). Panel C, model of amino acids 446-557 of EndoS using the LRR-region from InlB as the template. Panel A and C, beta-strands are shown in yellow, alpha-helices in purple, and loops in turquoise.
###end p 25
###begin p 26
###xml 270 282 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria spp</italic>
###xml 464 487 464 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria monocytogenes </italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 702 704 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1025 1037 1016 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 464 486 <span type="species:ncbi:1639">Listeria monocytogenes</span>
###xml 1025 1036 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1410 1415 <span type="species:ncbi:9606">human</span>
Since EndoS contains LRR's with similarities to other bacterial LRR proteins we attempted to generate a model of this region to investigate if EndoS has the potential of adopting a similar structure known to be important for protein-protein interaction and virulence in Listeria spp. Using the same approach as for the amino-terminal part we were able to construct a model of amino acids 446-577 of EndoS using the LRR region of Internalin B (InlB, PDB 1M9S) from Listeria monocytogenes as a template [35]. This model revealed a bowed tube structure with five parallel beta-strands forming a beta-sheet that constitute the concave face of the structure in a similar manner as can be seen in InlB (Fig. 4C). In the EndoS-LRR model there is only one complete beta-loop-helix-loop motif that can be seen in several LRR proteins including InlB. Furthermore, it is unclear from this model if the carboxy-terminal part of EndoS has the kind of cap structure that can be seen in InlB. Nevertheless, it is intriguing that a secreted S. pyogenes protein has structural similarity with LRR's of internalins that are crucial for cellular invasion and virulence. Furthermore, since the concave face of other LRR's including InlB has been suggested to be a major site for protein interactions, the model of the LRR region in EndoS could be used as a starting point for finding potential cellular and protein targets in the human host.
###end p 26
###begin title 27
Site-directed mutagenesis and chemical modification of tryptophans inactivates EndoS
###end title 27
###begin p 28
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 883 898 883 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lens culinaris </italic>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1129 1131 1129 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 504 509 <span type="species:ncbi:9606">human</span>
###xml 883 897 <span type="species:ncbi:3864">Lens culinaris</span>
Sequence analysis suggested that Glu-235 is part of the glycosyl hydrolase motif and possibly the catalytically active amino acid. Furthermore, the positioning of Glu-235 at the orifice of the -barrel as suggested by homology modeling identified this amino acid as prime catalytic residue candidate (Fig. 5A). Therefore we mutated Glu-235 in rEndoS to glutamine by site-directed mutagenesis of the ndoS gene and recombinantly expressed EndoS(E235Q). This protein was tested for activity against purified human IgG by SDS-PAGE and lectin blot analysis. This revealed that EndoS, but not EndoS(E235Q) could shift the apparent mass of the IgG heavy chain approx. 3 kDa (Fig 5B, Stain) indicating that EndoS(E235Q) has lost its activity on IgG. Furthermore, IgG heavy chains incubated with EndoS but not EndoS(E235Q) loose the reactivity against the mannose-specific biotinylated lectin Lens culinaris agglutinin (LCA) (Fig 5B, LCA-blot). We have previously shown that lack of lectin signal from IgG corresponds well to complete hydrolysis of the chitobiose core of the IgG-glycan as analyzed by mass spectroscopy of hydrolyzed IgG [36]. This experiment confirmed that Glu-235 is essential for the IgG-glycan hydrolyzing activity of EndoS.
###end p 28
###begin p 29
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Glutamic acid 235 and tryptophan residues are important for EndoS activity</bold>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 399 404 <span type="species:ncbi:9606">human</span>
Glutamic acid 235 and tryptophan residues are important for EndoS activity. Panel A, homology model of the amino-terminal part of EndoS with glutamic acid 235 (red) and the tryptophan residues (blue) are highlighted. Panel B, dilutions of rEndoS or rEndoS(E235Q) incubated with 1 mug human IgG for 1 hour at 37degreesC. IgG-glycan hydrolysis by EndoS was analyzed by SDS-PAGE and LCA-blot. Panel C, human IgG incubated with buffer, rEndoS modified with NEM, NBS, IAA, or unmodified (Buffer). The proteins were separated by SDS-PAGE, stained or analyzed for LCA reactivity in blot.
###end p 29
###begin p 30
###xml 233 234 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 274 292 271 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Batillus cornutus </italic>
###xml 302 316 299 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Turbo cornutus</italic>
###xml 347 349 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 510 531 507 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces griseus </italic>
###xml 532 534 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 535 537 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 813 815 810 812 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 820 822 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1223 1225 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1364 1366 1361 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 1506 1508 1503 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 274 291 <span type="species:ncbi:63673">Batillus cornutus</span>
###xml 302 316 <span type="species:ncbi:63673">Turbo cornutus</span>
###xml 510 530 <span type="species:ncbi:1911">Streptomyces griseus</span>
Another approach to investigate which amino acids that are important for enzymatic activity involves chemical modification of certain types of amino acids. It has previously been shown that chemical blocking of tryptophans in a beta-N-acetylglucosaminidase from the mollusk Batillus cornutus (formerly Turbo cornutus) inhibits chitinase activity [37]. Furthermore, tryptophans situated on extended loops outside the catalytic site are essential for substrate binding and enzymatic activity in a chitinase from Streptomyces griseus [38,39]. This was intriguing, since 8 tryptophans are present in the amino-terminal part of EndoS of which one is located inside the predicted -barrel with Glu-235 at the orifice, and three (two and one) in the predicted extended loops that distinguish EndoS from the template EndoF3 (Fig 5A). Furthermore, there are four more tryptophan residues in the carboxy-terminal part located carboxy-terminally to the LRR. Therefore we investigated if N-bromosuccinimide (NBS) could affect the enzymatic activity of EndoS. NBS can react with the indole group of tryptophan and with SH groups of cysteines and are commonly used for characterization amino acid residues involved in enzymatic activity [40]. After modification of EndoS with NBS, no IgG glycan hydrolysis could be seen as analyzed by SDS-PAGE and LCA lectin blot analysis (Fig. 5C, Stain and LCA-blot). Treatment of EndoS with iodoacetamide (IAA) or N-ethylmaleimide (NEM), reagents used for blockage of cysteines (Fig. 5C, Stain and LCA-blot, NEM and IAA), or modification of lysines using formaldehyde, did not affect the hydrolysis of IgG by EndoS (data not shown). These results suggest that lysine (constitutes 10% of the amino acids) and cysteine residues (one in the mature protein) in EndoS are not essential for the enzymatic activity, while tryptophans in the predicted beta-barrel, in the extended loops, and/or in the carboxy-terminal part are required for the IgG glycan-hydrolyzing activity of EndoS.
###end p 30
###begin title 31
SpeB ultimately inactivates EndoS
###end title 31
###begin p 32
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 553 564 553 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes</italic>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 553 564 <span type="species:ncbi:1314">S. pyogenes</span>
To investigate whether SpeB-hydrolyzed EndoS has activity on the glycan on IgG, rEndoS was treated for increasing amount of time with SpeB prior to incubation with human IgG. This revealed that SpeB hydrolyzes EndoS in a time-dependent manner and that after 2 hours of incubation virtually no full-length EndoS is present. The smaller protein fragment can still be detected after 4 hours and the larger fragment can be detected after 3 h (Fig. 6A). This corresponds well to the observations of the presence and state of the two enzymes during growth of S. pyogenes; when active SpeB starts to appear after 12-13 hours of growth the first signs of EndoS-hydrolysis can be seen, and 2-3 hours later no full-length EndoS can be detected (Fig. 1 and data not shown). Furthermore, the IgG glycan-hydrolyzing activities of the same samples were analyzed by SDS-PAGE and LCA lectin blot. This revealed that after 3 hours of incubation no IgG glycan hydrolyzing activity could be detected (Fig. 6B, Stain and LCA-blot). This indicates that full-length EndoS is required for activity on IgG and that SpeB eventually inactivates the IgG glycan-hydrolyzing activity of EndoS.
###end p 32
###begin p 33
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SpeB-hydrolyzed rEndoS loses activity on human IgG</bold>
###xml 41 46 <span type="species:ncbi:9606">human</span>
SpeB-hydrolyzed rEndoS loses activity on human IgG. Panel A, rEndoS was incubated with SpeB as described in material and methods at indicated time points and 10 mul of samples were applied on polyacrylamide gel and stained with Coomassie Blue. Panel B, 2 mul sample withdrawn from the same incubations, was incubated with 2 g IgG for 2 hours and IgG hydrolysis was analyzed by SDS-PAGE and LCA-blot.
###end p 33
###begin p 34
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1199 1211 1199 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1156 1161 <span type="species:ncbi:10090">mouse</span>
###xml 1199 1210 <span type="species:ncbi:1314">S. pyogenes</span>
In this study we show that EndoS and SpeB are coordinately expressed during growth in vitro, and that when SpeB maturates into its active form it starts to degrade EndoS, but two major fragments of 62 and 46 kDa seems somewhat more resistant to proteolysis. Fragments of similar sizes are also generated by the protease thermolysin suggesting that there are domains in EndoS that are partly protected against proteolysis, of which one most likely is the 62 kDa carboxy-terminal fragment identified by amino-terminal sequencing. SpeB-processing and/or degradation of proteins from the bacterium itself seem to be important mechanisms for inactivation or release of biologically active fragments or domains. SpeB processes the pore-forming streptolysin O [19], releases functional fragments from the cell-wall anchored C5a-peptidase and IgG-binding M proteins [18], and degrades the streptococcal superantigen SmeZ [20]. Such a process might be of importance in controlling the enzymatic activity of EndoS or to release fragments with biological activity, but at this point we could only substantiate the former. Interestingly, a recent study has shown in a mouse model of subcutaneous infection that S. pyogenes undergoes a stable phase shift to low SpeB production leading to production of intact forms of several putative and known virulence factors including EndoS [41]. This further emphasizes the role for SpeB in controlling the activity of other secreted and cell wall-anchored proteins during the infection process.
###end p 34
###begin p 35
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 196 203 <span type="species:ncbi:562">E. coli</span>
###xml 372 379 <span type="species:ncbi:562">E. coli</span>
Attempts to recombinantly express the amino- and carboxy-terminal parts of EndoS separately for functional studies have this far proven unsuccessful. The amino-terminal part could be expressed in E. coli, but the protein is degraded despite the use of protease-deficient host strains, while the gene fragment encoding the carboxy-terminal part could not be established in E. coli for unknown reasons (data not shown). Furthermore, we have not been able to separate the SpeB generated fragments of EndoS using gel filtration, ion-exchange chromatography, or affinity chromatography with immobilized EndoS antibodies (data not shown).
###end p 35
###begin p 36
###xml 778 790 778 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 778 789 <span type="species:ncbi:1314">S. pyogenes</span>
Homology modeling, site-directed mutagenesis, and chemical modification experiments of EndoS suggest that the amino-terminal part contains several key elements necessary for enzymatic activity on human IgG. The function of the carboxy-terminal part remains unknown, but the observation that only full-length EndoS has activity on IgG indicates that also this part of the protein is important for the interaction with IgG, either as necessary structural element or by direct interactions with IgG. The primary and possible structural similarities between EndoS and LRR's from other pathogenic bacteria suggest that it might have similar adhesive or invasive functions either as a liberated domain or in the intact enzyme. Interestingly, another recently identified extracellular S. pyogenes LRR protein; Slr (streptococcal leucine-rich repeat protein) is involved in virulence and phagocytosis resistance [42]. Our findings may in part explain why EndoS in contrast to many related endoglycosidases, that require or are enhanced by denaturation of the glycoprotein, only interacts with native IgG [34]. A protein-protein interaction between the enzyme and IgG involving tryptophan residues in EndoS could be part of this unique feature.
###end p 36
###begin p 37
###xml 114 126 114 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 714 726 714 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1060 1072 1060 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 1279 1291 1279 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 1364 1369 1364 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 114 125 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 714 725 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1060 1071 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 1279 1290 <span type="species:ncbi:1314">S. pyogenes</span>
It is currently not known how the IgG-hydrolyzing activities of SpeB and EndoS contributes to the pathogenesis of S. pyogenes infections, even though the attenuation seen in SpeB mutants might include loss of activity agianst IgG. There are fundamental differences between the two enzymes despite their shared substrate; SpeB is a broad spectrum protease with activities against a whole array of host proteins while EndoS is very specific for IgG. This might give a hint about their respeictive contribution to IgG hydrolysis. SpeB most likely contributes to IgG hydrolysis during infections but there will be many competing substrates that will lower the effeciency against IgG. It should also be mentioned, that S. pyogenes possesses another cysteine proteinase, IdeS, that in contrast to SpeB only hydrolyzes IgG [43]. EndoS on the other hand could at low concentrations efficeintly incapacitate IgG during certain stages of the infection. Our current model hypothesizes that EndoS most likely plays a minor role in animals without aquired immunity towards S. pyogenes and only comes into play when there are circulating antibodies towards the bacteria. We are currently setting up animal models to test this hypothesis. Animals will be immunized with surface structures from S. pyogenes prior to challenge with wild type bacteria and an isogenic mutant in the ndoS gene. This might help us to further elucidate the role for EndoS during infections.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 437 446 437 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 256 261 <span type="species:ncbi:9606">human</span>
The cysteine proteinase SpeB processes, inactivates, and ultimately degrades the IgG glycan-hydrolyzing enzyme EndoS. Glutamic acid 235 in EndoS is required for glycan-hydrolyzing activity and tryptophans in EndoS are involved in the enzymatic activity on human IgG. This is important information for future studies of the function and presence of EndoS in various systems. Since SpeB and EndoS are expressed during the same conditions (in vitro and possibly during some conditions in vivo), researchers setting out to study EndoS are bound to experience degradation/inactivation of EndoS if not the temporal production and activity of both enzymes are taken into account.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
Bacteria and growth conditions
###end title 41
###begin p 42
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 605 606 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 608 609 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 622 623 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 4 15 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 530 535 <span type="species:ncbi:4932">yeast</span>
The S. pyogenes strains that were used in this study are AP1 of serotype M1 from the WHO Collaborating Center for Reference and Research on Streptococci, Prague, Czech Republic; AL1, an isogenic mutant of AP1 lacking production of active SpeB generated as previously described [2,24]; MC14, an isogenic mutant of AP1 lacking production of EndoS generated as previously described [2]. For maximal SpeB and EndoS expression, C-medium (CM) was used consisting of 0.5% (w/v) Proteose Peptone No. 2 (Difco, Detroit, MI) and 1.5% (w/v) yeast extract (Oxoid, Basingstoke, England) dissolved in CM buffer (10 mM K2PO4, 0.4 mM MgSO4, and 17 mM NaCl pH 7.5) [21]. When appropriate, a final concentration of 5 mM dithiothreitol (DTT) was added to the growth medium to activate SpeB. Strains AL1 and MC14 were cultured in the presence of 200 mug/ml of kanamycin for selective pressure.
###end p 42
###begin title 43
Protein electrophoresis and Western blots
###end title 43
###begin p 44
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 410 411 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 306 312 <span type="species:ncbi:9986">rabbit</span>
Culture supernatants were precipitated using trichloroacetic acid at a final concentration of 5% and separated by 10% SDS-PAGE [44] followed by transfer to PVDF membranes (Immobilon-P, Millipore, Bedford, MA) by electroblotting. Secretion of SpeB and EndoS was analyzed using Western blots with polyclonal rabbit antiserum raised against the zymogen form of SpeB and full-length EndoS as previously described [2,45]. Densitometric analysis of stained SDS-PAGE gels was performed using the public domain software ImageJ 1.39f developed by Wayne Rasband at the National Institutes of Health .
###end p 44
###begin title 45
Proteins and enzyme activity assays
###end title 45
###begin p 46
###xml 153 170 153 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 281 293 281 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pyogenes </italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 826 828 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1214 1220 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans-</italic>
###xml 1308 1310 1281 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1664 1679 1628 1643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lens culinaris </italic>
###xml 153 169 <span type="species:ncbi:562">Escherichia coli</span>
###xml 281 292 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 1476 1481 <span type="species:ncbi:9606">human</span>
###xml 1664 1678 <span type="species:ncbi:3864">Lens culinaris</span>
###xml 1732 1743 <span type="species:ncbi:3704">Horseradish</span>
Full-length EndoS with (GST-EndoS) or without (rEndoS) glutathione-S-transferase (GST) as a fusion partner was recombinantly expressed and purified from Escherichia coli harboring the plasmid pGEXndoS as previously described [34]. The native zymogen form of SpeB was purified from S. pyogenes strain AP1 using ion-exchange chromatography as previously described [18]. The immunoglobulins used in all experiments were affinity purified pooled human polyclonal IgG (Sigma, St. Louis, MO). For testing of SpeB activity on EndoS, 30 mug of rEndoS was incubated for 2 hours at 37degreesC with 1, 0.2, 0.04, or 0.008 mug of purified SpeB in 20 mul PBS with a 10 mM final concentration of DTT followed by 10% SDS-PAGE analysis. For testing of thermolysin degradation 10 mug of rEndoS was incubated with 1 mug of thermolysin (Sigma) [46] for 1 hour at 37degreesC in 10 mM Tris-HCl (pH 7.4) and analyzed on SDS-PAGE as above. Alternatively, 30 mug of rEndoS was incubated at 37degreesC with a fixed amount of SpeB (6 mug) in a final volume of 120 mul under the same conditions as above and samples were withdrawn at 1 or 30 min, and 1, 2, 3 or 4 hours. Reactions were terminated by a final concentration of 100 muM E-64 (L-trans-epoxysuccinylleucylamido(4-guanidino)butane), a specific cysteine proteinase inhibitor [47] followed by 10%SDS-PAGE analysis. EndoS activity on IgG was measured by withdrawing 2 mul of samples from the above mixture and incubated it with 2 mug of purified human IgG for 2 hours at 37degreesC followed by separation by 10% SDS-PAGE, or electroblotted onto PVDF membranes (Millipore). Glycosylated IgG was detected using 5 mug/ml of biotinylated Lens culinaris agglutinin lectin (LCA) and 1 mug/ml of Streptavidin-Horseradish peroxidase (Vector Laboratories, Burlingame, CA) and SuperSignal West Pico peroxidase substrate (Pierce, Rockford, IL). Membranes were analyzed using a Chemidoc XRS imaging system and Quantity One image analysis software (Bio-Rad, Hercules, CA).
###end p 46
###begin title 47
Homology modeling
###end title 47
###begin p 48
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 57 88 57 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Elizabethkingia meningoseptica </italic>
###xml 98 128 98 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Flavobacterium meningosepticum</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 252 254 252 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 57 87 <span type="species:ncbi:238">Elizabethkingia meningoseptica</span>
###xml 98 128 <span type="species:ncbi:238">Flavobacterium meningosepticum</span>
###xml 147 153 <span type="species:ncbi:13443">Coffee</span>
Amino acids 37-446 of EndoS was aligned with EndoF3 from Elizabethkingia meningoseptica (formerly Flavobacterium meningosepticum) [33] using the T-Coffee method [48] and submitted to the SWISS-MODEL automated protein homology server [49,50] using EndoF3 (PDB 1EOK) as the template. The generated model was visualized using the VMD 1.8.5 software [51] and high resolution images were generated using POV-Ray 3 [52] running on a Mac OS X workstation.
###end p 48
###begin title 49
Chemical modification of EndoS
###end title 49
###begin p 50
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 196 197 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 200 201 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 408 409 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 412 413 408 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 674 679 <span type="species:ncbi:9606">human</span>
Chemical modification of tryptophan residues was performed according to [37]. Briefly, 20 mug of rEndoS was incubated with 0.5 mM N-bromosuccinimide (NBS) (Sigma) in 20 mul of 0.1 M citric acid-Na2HPO4, pH 4.5 for 30 minutes at room temperature. Chemical modification of cysteine residues as performed by incubating 20 mug of rEndoS with 10 mM N-ethylmaleimide (NEM) (Sigma) in 20 mul of 0.1 M citric acid-Na2HPO4, pH 6 for 30 minutes at room temperature or with 20 mM iodoacetamide (IAA) (Sigma) in 20 mM Tris-HCl, pH 8.5 for 30 minutes at room temperature. For determination of enzymatic activity, 0.5 mug rEndoS from the above reaction mixtures was incubated with 10 mug human IgG in 20 mM Tris-HCl, pH 7.4 for 2 hours at 37degreesC. Samples were separated by 10% SDS-PAGE and stained with Coomassie or electroblotted onto PVDF for analysis with LCA lectin blot as above.
###end p 50
###begin title 51
Site-directed mutagenesis of EndoS
###end title 51
###begin p 52
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS </italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ndoS</italic>
Mutation of glutamic acid 235 (Glu-235) into glutamine (E235Q) was performed using QuickChange II Site-Directed Mutagenesis Kit according to manufacturer's instructions (Stratagene, La Jolla, CA). The mutagenic oligonucleotide primers (mutation underlined) used was 5'-CCT TGA TGG CTT AGA TGT GGA TGT TCA ACA TGA TAG TAT TCC-3' for E235Q in combination with the anti-sense of the above sequences and the plasmid pGEXndoS generating plasmid pGEXndoS(E235Q). Mutation was verified by sequencing. Recombinant EndoS(E235Q) was expressed and purified as described above for EndoS.
###end p 52
###begin title 53
Authors' contributions
###end title 53
###begin p 54
MA participated in the design of the study and performed the experiments. MC and AO conceived of the study and participated in its design. MC performed sequence alignments and homology modeling, and drafted the manuscript. All authors read and approved the final manuscript.
###end p 54
###begin title 55
Acknowledgements
###end title 55
###begin p 56
Ulla Johannesson is acknowledged for excellent technical assistance. This work was supported by grants from the Swedish Research Council (project 2005-4791), the Foundations of Crafoord, Jeansson, Zoega, Bergvall, Osterlund, Groschinsky, and the Swedish Society for Medical Research, the Swedish Society of Medicine, the Royal Physiografic Society, and the Medical Faculty at Lund University. M.C. is the recipient of an Assistant Professorship from Swedish Research Council.
###end p 56
###begin article-title 57
###xml 81 103 81 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes</italic>
###xml 81 103 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes
###end article-title 57
###begin article-title 58
###xml 37 60 37 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 37 59 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG
###end article-title 58
###begin article-title 59
###xml 20 43 20 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 20 42 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis
###end article-title 59
###begin article-title 60
###xml 59 82 59 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 59 81 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease
###end article-title 60
###begin article-title 61
###xml 48 62 48 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus </italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes
###end article-title 61
###begin article-title 62
Endoglycosidase treatment abrogates IgG arthritogenicity - importance of IgG glycosylation in arthritis
###end article-title 62
###begin article-title 63
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection
###end article-title 63
###begin article-title 64
Effect of group A streptococcal cysteine protease on invasion of epithelial cells
###end article-title 64
###begin article-title 65
###xml 68 91 68 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 68 90 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome
###end article-title 65
###begin article-title 66
###xml 72 95 72 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 72 94 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Activation of a 66-kDa human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine proteinase
###end article-title 66
###begin article-title 67
###xml 27 50 27 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 27 49 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity
###end article-title 67
###begin article-title 68
###xml 130 152 121 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes</italic>
###xml 130 152 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
Cleavage of interleukin 1beta (IL-1beta) precursor to produce active IL-1beta by a conserved extracellular cysteine protease from Streptococcus pyogenes
###end article-title 68
###begin article-title 69
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37
###end article-title 69
###begin article-title 70
Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin
###end article-title 70
###begin article-title 71
###xml 73 87 73 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus </italic>
###xml 159 164 <span type="species:ncbi:9606">human</span>
A natural variant of the cysteine proteinase virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3
###end article-title 71
###begin article-title 72
Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism
###end article-title 72
###begin article-title 73
###xml 12 35 12 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 12 34 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin
###end article-title 73
###begin article-title 74
Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins
###end article-title 74
###begin article-title 75
###xml 46 69 46 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 76 93 76 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 46 68 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 76 92 <span type="species:ncbi:562">Escherichia coli</span>
Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease
###end article-title 75
###begin article-title 76
Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB
###end article-title 76
###begin article-title 77
Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor
###end article-title 77
###begin article-title 78
Chemical properties of streptococcal proteinase and its zymogen
###end article-title 78
###begin article-title 79
A protein sequenator
###end article-title 79
###begin article-title 80
###xml 87 107 <span type="species:ncbi:36470">group A streptococci</span>
Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci
###end article-title 80
###begin article-title 81
Structural and sequence-based classification of glycoside hydrolases
###end article-title 81
###begin article-title 82
###xml 58 83 58 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Porphyromonas gingivalis </italic>
###xml 58 93 <span type="species:ncbi:242619">Porphyromonas gingivalis strain W83</span>
Complete genome sequence of the oral pathogenic bacterium Porphyromonas gingivalis strain W83
###end article-title 82
###begin article-title 83
###xml 23 41 23 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Clostridium tetani</italic>
###xml 23 41 <span type="species:ncbi:1513">Clostridium tetani</span>
The genome sequence of Clostridium tetani, the causative agent of tetanus disease
###end article-title 83
###begin article-title 84
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria </italic>
Comparative genomics of Listeria species
###end article-title 84
###begin article-title 85
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Listeria </italic>
A framework for interpreting the leucine-rich repeats of the Listeria internalins
###end article-title 85
###begin article-title 86
###xml 83 100 83 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L. monocytogenes </italic>
###xml 83 99 <span type="species:ncbi:1639">L. monocytogenes</span>
E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells
###end article-title 86
###begin article-title 87
RADAR: Rapid Automatic Detection and Alignment of Repeats in protein sequences
###end article-title 87
###begin article-title 88
Structures and mechanisms of glycosyl hydrolases
###end article-title 88
###begin article-title 89
Structural basis for the substrate specificity of endo-beta-N-acetylglucosaminidase F3
###end article-title 89
###begin article-title 90
###xml 30 53 30 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pyogenes </italic>
###xml 30 52 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins
###end article-title 90
###begin article-title 91
###xml 112 128 112 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L. monocytogenes</italic>
###xml 112 128 <span type="species:ncbi:1639">L. monocytogenes</span>
Structure of the lnlB leucine-rich repeats, a domain that triggers host cell invasion by the bacterial pathogen L. monocytogenes
###end article-title 91
###begin article-title 92
###xml 38 60 38 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Enterococcus faecalis </italic>
###xml 38 59 <span type="species:ncbi:1351">Enterococcus faecalis</span>
###xml 77 82 <span type="species:ncbi:9606">human</span>
A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B
###end article-title 92
###begin article-title 93
###xml 90 105 90 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Turbo cornutus </italic>
###xml 90 104 <span type="species:ncbi:63673">Turbo cornutus</span>
The chemical modification of the essential groups of beta-N-acetyl-D-glucosaminidase from Turbo cornutus Solander
###end article-title 93
###begin article-title 94
###xml 90 111 90 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces griseus </italic>
###xml 90 110 <span type="species:ncbi:1911">Streptomyces griseus</span>
Importance of Trp59 and Trp60 in chitin-binding, hydrolytic, and antifungal activities of Streptomyces griseus chitinase C
###end article-title 94
###begin article-title 95
###xml 50 71 50 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptomyces griseus </italic>
###xml 50 70 <span type="species:ncbi:1911">Streptomyces griseus</span>
Structural studies of a two-domain chitinase from Streptomyces griseus HUT6037
###end article-title 95
###begin article-title 96
Chemical modification of an alpha 3-fucosyltransferase; definition of amino acid residues essential for enzyme activity
###end article-title 96
###begin article-title 97
###xml 22 36 22 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus </italic>
Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB
###end article-title 97
###begin article-title 98
###xml 70 84 70 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus </italic>
###xml 105 127 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins
###end article-title 98
###begin article-title 99
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G
###end article-title 99
###begin article-title 100
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
###end article-title 100
###begin article-title 101
Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein
###end article-title 101
###begin article-title 102
Amino acid sequence of thermolysin. Isolation and characterization of the fragments obtained by cleavage with cyanogen bromide
###end article-title 102
###begin article-title 103
L-trans-Epoxysuccinyl-leucylamido (4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L
###end article-title 103
###begin article-title 104
###xml 2 8 <span type="species:ncbi:13443">Coffee</span>
T-Coffee: A novel method for fast and accurate multiple sequence alignment
###end article-title 104
###begin article-title 105
SWISS-MODEL: An Automated Comparative Protein Modelling Server
###end article-title 105
###begin article-title 106
SWISS-MODEL: An automated protein homology-modeling server
###end article-title 106
###begin article-title 107
VMD: Visual molecular dynamics
###end article-title 107
###begin article-title 108
Pov-Ray: The Persistence of Vision Raytracer
###end article-title 108

